ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Garg Pushkal โ EVP Chief R&D
Shares
4,579
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 12, 2026
EPS:0.82 (est: 1.16)-29.3%
Revenue:$1.10B (est: $1.15B)-4.5%
Transaction Details
| Insider | Garg Pushkal |
|---|---|
| Title | EVP Chief R&D |
| Transaction Date | Feb 12, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Shares Purchased | 4,579 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 27,090 |
| Derivative | No |
| Accession Number | 0001735276-26-000029 |
| Document | View SEC Filing |